Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Primary Care Doctors Help Boost Life Spans, But More Are NeededMore Car Crashes Tied to Drivers High on OpioidsPoor Whites Bear the Brunt of U.S. Opioid Crisis, Studies FindFDA to Tighten Oversight of SupplementsAs U.S. Measles Outbreaks Spread, Why Does 'Anti-Vax' Movement Persist?Even Brief EMS Delay Can Cost Lives After Car CrashHealth Tip: Know Your Family's Medical HistoryPatients With Primary Care Docs May Get Better Health CareIs Brexit a Health Hazard?Blood Donors Needed as Cold Weather Freezes U.S. SupplyMedical Scribes Could Help Improve ER CareAHA: Medical Experts 'Sound the Alarm' on Medical MisinformationWhite House Plan to Disclose Drug Prices May Not Drive Down Costs: StudyCan Artificial Intelligence Read X-Rays?Virtual Doctor Visits Get High Marks in New SurveyBig Pharma's Marketing to Docs Helped Trigger Opioid Crisis: StudyDisrupted Sleep Plagues Hospital Patients, But New Program Might HelpOpioid Prescriptions Almost Twice as Likely for Rural vs. Urban AmericansClimate Change Already Hurting Human Health, Review ShowsCalling All Blood Donors …Even Older Drugs Are Getting Steep Price Hikes, Study FindsAs Medical Marketing Soars, Is Regulation Needed?Radiation Doses From CT Scans Vary WidelyU.S. Leads Health Care Spending Among Richer Nations, But Gets LessIs Your State a Hotspot for Obesity-Linked Cancers?Health Tip: Choose the Right DoctorFDA Warns Companies on Dangerous, Unapproved Stem Cell TreatmentsMore U.S. Kids Dying From Guns, Car AccidentsRoad Rules on Smartphone Use Are Saving Bikers' Lives, TooAHA: Should Pacemakers, Defibrillators Be Recycled -- and Reused in Others?California Farm Tied to E. coli Outbreak Expands Recall Beyond Romaine LettuceHealth Tip: Use Medical Devices SafelyCalifornia Farm Implicated in Outbreak of E. coli Tied to Romaine LettuceFentanyl Now the No. 1 Opioid OD KillerHospitalizations Rising Among the HomelessElectronic Health Records Bogging Docs DownMore Are Seeking Mental Health Care, But Not Always Those Who Need It MostMillions of Americans Still Breathing Secondhand Smoke: ReportNew Approach to Opioid Crisis: Supervised Heroin Injection Programs?Many Americans Unaware of Promise of Targeted, 'Personalized' Medicine: PollAs Gun Violence Grows, U.S. Life Expectancy DropsMost Americans Lie to Their DoctorsOpioid Crisis, Suicides Driving Decline in U.S. Life Expectancy: CDCWant to Learn CPR? Try an Automated KioskHealth Surrogates Often in Dark About Loved One's WishesRestaurant 'Health Grade' Posters Could Mean Safer DiningSmoking Bans Might Help Nonsmokers' Blood PressureWarmer Winters, More Violent Crimes?Are Food Additives Good or Bad? Consumer Views VaryDrug Studies in Children Often Go Unfinished: Study
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

White House Wants Prices in Drug Ads, But Big Pharma Fights Back

HealthDay News
by By Dennis Thompson
HealthDay Reporter
Updated: Oct 15th 2018

new article illustration

MONDAY, Oct. 15, 2018 (HealthDay News) -- In an attempt to head off federal regulation, America's pharmaceutical manufacturers announced Monday that they would take voluntary action to make drug prices more transparent.

Under the industry's plan, all TV drug advertisements would include information directing consumers to online resources that provide the drug's list price, estimated out-of-pocket costs for consumers, and any available financial assistance for patients.

The Pharmaceutical Research and Manufacturers of America (PhRMA) announced the voluntary plan ahead of new proposed federal regulations that would require the companies to include list prices of drugs in all consumer ads.

The Trump administration is expected to announce the proposed regulations this week, according to Politico.

"We think putting the list price in isolation in the ads themselves is very confusing, misleading, lacks appropriate context and isn't what patients want or need," said Stephen Ubl, president and CEO of PhRMA.

Most people don't pay list price for their medication, Ubl noted. For example, people with insurance are usually only charged a co-payment for their prescription, and others might be eligible for patient assistance through the drug maker.

The plan will become effective in April 2019, but Ubl expects that some companies will begin providing more price information in a matter of months.

In announcing the plan, Ubl said PhRMA was responding to political and consumer pressure for more transparency.

"The president challenged us to provide this information. Policymakers on a bipartisan basis have. We take these concerns very seriously," Ubl said.

PhRMA fashioned its plan based on consumer focus groups and polls, Ubl said.

"What we heard is patients do want more information about their medicine costs, but they want information they can act upon," Ubl said. "They want to know if their medicine is covered by their insurer, what they will have to pay out-of-pocket for their medicines, and whether any financial assistance is available."

However, under the PhRMA plan, individual drug companies would have a lot of leeway regarding how they refer people to drug-pricing information, as well as the specific price info presented to consumers online, Ubl said.

"There are anti-trust limitations regarding the specificity of guidance we can give our members," Ubl said.

For example, the voluntary plan cannot specify how prominent the pricing info referral would have to be in a drug advertisement, Ubl said.

"The ad itself, either through voiceover or text, will direct the patient to a company-specific website, which will include list price of the medicine, estimated range of out-of-pocket costs, and other appropriate information," Ubl said.

Given this, consumers might be forced to quickly jot down a web address spoken out loud during an ad.

The plan also does not provide specific guidance regarding how each company would determine and present the range of out-of-pocket costs a person might face when buying a drug.

"There are various vendors that exist today that have developed calculators of this sort. I expect those tools will be employed to provide this information," Ubl said.

PhRMA also announced that it will launch a new website in cooperation with patient, pharmacist and consumer groups to provide searchable cost and financial assistance information for brand-name medicines. The website is expected to launch early next year, Ubl said.

In a Monday media briefing, PhRMA officials did not rule out legal action if the Trump administration presses forward with its expected regulations.

"Any such requirement would raise significant legal issues, including First Amendment concerns," Ubl said.

When asked if there was any way policymakers could craft regulations on drug-pricing information without raising constitutional questions, Ubl replied, "No, we don't think that they could."

More information

PhRMA has more about its principles regarding direct-to-consumer advertisements.




Facebook

Amazon Smile

To quit smoking, call Connecticut QuitLine at 1-800-QUIT-NOW.

Children and Adult services are available now with no wait time.  Please contact HBH Intake Department at 860-548-0101, option 2.

 


powered by centersite dot net